Genomics England was set up in 2013 as a company wholly owned by the Department of Health. Their task is to deliver the 100,000 Genomes Project, a flagship project that will sequence 100,000 whole genomes from NHS patients with rare disease and their families, and common cancers. There’s also an infectious diseases part which is being run by Public Health England.
For rare disease patients, Genomics England will aim to provide genomic diagnoses for the first time. For patients with cancer, there is the potential for more personalised treatments and in time, the project will lead to the development of new or more effective diagnostics and treatments. By the end of this project, Genomics England will have put in place the infrastructure, training, and systems to enable the NHS to offer genomic medicine to those who need it. This is currently the largest project of its kind in the world and it puts the UK forefront of transforming healthcare through genomics.
Genomics England is working with NHS England, Health Education England and Public Health England to deliver the project. There are thirteen NHS Genomic Medicine Centres (GMCs) across England to recruit patients, take the samples and provide medical information to the project. Initiatives in Scotland, Northern Ireland and Wales are also being set up.
Here are some of the exciting milestones reached by the Genomics England team:
Click here, for the most up-to-date list of current job opportunities at Genomics England.
The Campus is home to a range of partner companies, facilities, and cross-cutting activities.
Learn more